Laura Sutcliffe
Stock Analyst at Citigroup
(0.73)
# 4,152
Out of 5,150 analysts
11
Total ratings
45.45%
Success rate
-11.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLX Telix Pharmaceuticals | Maintains: Buy | $22 → $23 | $6.87 | +227.51% | 4 | Feb 24, 2026 | |
| RMD ResMed | Maintains: Buy | $330 → $345 | $259.05 | +33.18% | 4 | Feb 2, 2026 | |
| ARGX argenx SE | Initiates: Buy | $390 | $749.56 | -47.97% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $33.69 | - | 2 | Dec 20, 2019 |
Telix Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $22 → $23
Current: $6.87
Upside: +227.51%
ResMed
Feb 2, 2026
Maintains: Buy
Price Target: $330 → $345
Current: $259.05
Upside: +33.18%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $749.56
Upside: -47.97%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $33.69
Upside: -